|
EP0957073A1
(en)
*
|
1998-05-12 |
1999-11-17 |
Schwarz Pharma Ag |
Novel derivatives of 3,3-diphenylpropylamines
|
|
WO2003064501A1
(en)
*
|
2002-01-31 |
2003-08-07 |
Clarke Slemon |
Conformationally restricted compounds as dendrimer cores
|
|
US6703504B2
(en)
|
2002-02-11 |
2004-03-09 |
Clarke Slemon |
Conformationally constrained compounds as dendrimer cores
|
|
EP1424079A1
(en)
*
|
2002-11-27 |
2004-06-02 |
Boehringer Ingelheim International GmbH |
Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
|
|
DE10315917A1
(de)
*
|
2003-04-08 |
2004-11-18 |
Schwarz Pharma Ag |
Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
|
|
ITMI20031354A1
(it)
*
|
2003-07-02 |
2005-01-03 |
Istituto Di Chimica Biomolecolare D El Cnr Sezione |
Sintesis enantioselettiva di composti enantiomericamente arricchiti.
|
|
ES2235648B1
(es)
*
|
2003-12-22 |
2006-11-01 |
Ragactives, S.L. |
Procedimiento para la obtencion de tolterodina.
|
|
ITMI20040616A1
(it)
*
|
2004-03-30 |
2004-06-30 |
Dinamite Dipharma S P A In For |
Processo per la preparazione di tolterodina e suoi intermedi
|
|
EP1629834A1
(en)
|
2004-08-27 |
2006-03-01 |
KRKA, D.D., Novo Mesto |
Sustained release pharmaceutical composition of tolterodine
|
|
ITMI20041920A1
(it)
*
|
2004-10-11 |
2005-01-11 |
Chemi Spa |
Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
|
|
JP4513535B2
(ja)
*
|
2004-12-03 |
2010-07-28 |
住友化学株式会社 |
トルテロジンの製造方法
|
|
AU2005318426B2
(en)
*
|
2004-12-24 |
2011-05-19 |
Lek Pharmaceuticals D.D. |
Process for preparation of 3-(2-hydroxy-5-methylphenyl)-N,N-diisopropyl-3-phenylpropylamine
|
|
US7528267B2
(en)
|
2005-08-01 |
2009-05-05 |
Girindus America, Inc. |
Method for enantioselective hydrogenation of chromenes
|
|
ES2268987B1
(es)
|
2005-08-05 |
2008-02-01 |
Ragactives, S.L. |
Procedimiento para la obtencion de 3,3-difenilpropilaminas.
|
|
KR100647068B1
(ko)
|
2005-09-15 |
2006-11-23 |
하나제약 주식회사 |
라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
|
|
KR100686351B1
(ko)
*
|
2006-01-12 |
2007-02-22 |
주식회사 카이로제닉스 |
톨테로딘 라세미체의 제조방법
|
|
ATE480531T1
(de)
|
2006-05-24 |
2010-09-15 |
Pfizer Ltd |
Verfahren zur herstellung von benzopyran-2- olderivaten
|
|
EA018376B1
(ru)
|
2006-06-12 |
2013-07-30 |
Шварц Фарма Аг |
Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов
|
|
KR100717361B1
(ko)
*
|
2006-08-07 |
2007-05-11 |
주식회사 카이로제닉스 |
톨테로딘 라세미체 및 이의 중간체의 제조방법
|
|
EP2175843B1
(en)
|
2007-08-08 |
2014-10-08 |
Inventia Healthcare Private Limited |
Extended release compositions comprising tolterodine
|
|
RU2554347C2
(ru)
|
2008-08-19 |
2015-06-27 |
Ксенопорт, Инк. |
Пролекарства метилгидрофумарата, фармацевтические композиции с ними и способы применения
|
|
CN102307852B
(zh)
|
2008-12-24 |
2013-12-18 |
第一三共株式会社 |
环状胺化合物
|
|
NZ593676A
(en)
|
2008-12-24 |
2012-06-29 |
Daiichi Sankyo Co Ltd |
Calcium-sensing receptor antagonists
|
|
KR101275984B1
(ko)
*
|
2010-10-18 |
2013-06-18 |
경기대학교 산학협력단 |
광학활성을 갖는 크로만계 유도체 및 이의 제조방법
|
|
EP2639216B1
(en)
*
|
2010-11-09 |
2018-07-11 |
Kaneka Corporation |
Halogenated indenones and method for producing optically active indanones or optically active indanols by using same
|
|
WO2012098044A1
(en)
|
2011-01-17 |
2012-07-26 |
Cambrex Profarmaco Milano S.R.L. |
Process for the preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
|
|
EP2476665A1
(en)
|
2011-01-17 |
2012-07-18 |
Cambrex Profarmaco Milano S.r.l. |
Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
|
|
DK2720989T3
(en)
|
2011-06-20 |
2016-11-28 |
H Lundbeck As |
Deuterated 1-piperazino-3-phenyl-indanes used to treat schizophrenia
|
|
CN103159657B
(zh)
*
|
2011-12-08 |
2016-06-29 |
重庆华邦胜凯制药有限公司 |
一种定向合成不饱和共轭醇的方法
|
|
AR094054A1
(es)
*
|
2012-12-19 |
2015-07-08 |
H Lundbeck As |
6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma
|
|
KR101380982B1
(ko)
|
2013-04-29 |
2014-04-10 |
경기대학교 산학협력단 |
광학활성을 갖는 크로만-2-올 유도체 및 이의 제조방법
|
|
WO2017137955A1
(en)
|
2016-02-14 |
2017-08-17 |
Celestis Pharmaceuticals Pvt. Ltd. |
Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol
|
|
WO2018013739A2
(en)
*
|
2016-07-12 |
2018-01-18 |
Chromocell Corporation |
Compounds, compositions, and methods for modulating sweet taste
|
|
WO2020114853A1
(en)
|
2018-12-03 |
2020-06-11 |
H. Lundbeck A/S |
Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine
|